Key facts
- This page summarizes Anne Jones's Form 4 filing for Celularity Inc (CELU).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Nov 2022, 19:16.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Tax liability
Additional SEC filing notes
Footnote F1
These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date.
Footnote F2
Represents 52,888 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.
Footnote F3
Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under the 2021 Plan and does not represent a sale.
Footnote F4
Includes 40,388 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting.